Table 1.
Demographics and vaccine metrics of n=142 PWID receiving COVID-19 vaccination at a clinic co-located with BCHD SSP
| Variable | n | (%) |
|---|---|---|
| Age | ||
| Mean (s.d.) | 51.0 | (13.4) |
| Sex/Gender1 | ||
| Male | 102 | (72.0) |
| Female | 40 | (28.0) |
| Race | ||
| Black | 114 | (80.3) |
| White | 19 | (13.4) |
| Other/Unknown race | 9 | (6.3) |
| Ethnicity | ||
| Hispanic | 4 | (2.8) |
| Non-Hispanic | 138 | (97.2) |
| Preferred Language | ||
| English | 139 | (97.9) |
| Spanish | 3 | (2.1) |
| Housing Status2 | ||
| Residential address listed | 121 | (85.2) |
| No valid address listed | 21 | (14.8) |
| Insurance | ||
| Medicare | 5 | (3.5) |
| Medicaid | 64 | (45.0) |
| Private | 3 | (2.1) |
| Self-pay/special billing | 4 | (2.7) |
| None | 65 | (46.7) |
| First-dose Vaccine | ||
| Janssen | 69 | (48.6) |
| Pfizer | 70 | (49.3) |
| Moderna | 3 | (2.1) |
| 2-dose completion (n=73) | ||
| Completed entire series at SSP | 27 | (37.0) |
| First dose received at SSP- finished elsewhere | 20 | (27.4) |
| First dose received at SSP- incomplete series | 21 | (28.8) |
| First dose elsewhere- finished with SSP | 5 | (6.8) |
| Booster uptake | ||
| Completed 2-dose series | 22 | (42) |
| Completed 1 dose series | 19 | (27.5) |
1
Due to lack of data on patient’s gender, their sex identified at birth is reflected in the data. For those with gender identity specified in the EMR, their sex at birth has been replaced with their identified gender.
2
Patients were classified as having “residential address listed” if they had a residential address listed in the EMR; “no valid address listed” included non-residential addresses or if address was unknown